ProCE Banner Activity

Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer

Podcast Episodes

Listen to this podcast featuring a multidisciplinary discussion between Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, for expert guidance on optimal biomarker testing to guide treatment decisions in advanced prostate cancer.

Released: March 28, 2024

Expiration: March 27, 2025

Share

Faculty

Heather H. Cheng

Heather H. Cheng, MD, PhD

Associate Professor
Department of Medicine (Hematology and Oncology)
University of Washington
Division of Clinical Research
Fred Hutchinson Cancer Center
Seattle, Washington

Colin C. Pritchard

Colin C. Pritchard, MD, PhD

Co-Director
Genetics and Solid Tumors Laboratory
University of Washington Medical Center
Professor
Department of Laboratory Medicine and Pathology
University of Washington
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC in partnership with the American Society for Clinical Pathology

ProCE Banner

Supporters

Supported by an educational grant from Pfizer, Inc.

Pfizer, Inc.

Partners

American Society for Clinical Pathology

ProCE Banner

Disclosure

Primary Author

Heather H. Cheng, MD, PhD

Associate Professor
Department of Medicine (Hematology and Oncology)
University of Washington
Division of Clinical Research
Fred Hutchinson Cancer Center
Seattle, Washington

Heather H. Cheng, MD, PhD: researcher (paid to institution): Clovis Oncology, Color Genomics, Janssen, Medivation, Promontory Pharmaceutics, Sanofi. 

Colin C. Pritchard, MD, PhD

Co-Director
Genetics and Solid Tumors Laboratory
University of Washington Medical Center
Professor
Department of Laboratory Medicine and Pathology
University of Washington
Seattle, Washington

Colin C. Pritchard, MD, PhD, has no relevant financial relationships to disclose.